Collection of Czechoslovak Chemical Communications - digital archive 

Crossref Cited-by Linking

• D’Arrigo Paola, Cerioli Lorenzo, Fiorati Andrea, Servi Stefano, Viani Fiorenza, Tessaro Davide: Naphthyl-l-α-amino acids via chemo-enzymatic dynamic kinetic resolution. Tetrahedron: Asymmetry 2012, 23, 938. <https://doi.org/10.1016/j.tetasy.2012.06.020>
• Sobocińska M, Lempicka E, Konieczna E, Derdowska I, Lammek B, Melhem S, Kozik W, Janecka J, Janecki M, Trzeciak H I: Analogues of Arginine Vasopressin Modified in Position 2 or 3 with Naphthylalanine: Selective Antagonists of Oxytocin In-vitro. Journal of Pharmacy and Pharmacology 2010, 52, 1105. <https://doi.org/10.1211/0022357001775038>
• Stoev Stoytcho, Cheng Ling Ling, Manning Maurice, Wo Nga Ching, Szeto Hazel H.: Design and synthesis of potent, highly selective vasopressin hypotensive agonists. J. Pept. Sci. 2006, 12, 592. <https://doi.org/10.1002/psc.756>
• Kowalczyk Wioleta, Prahl Adam, Derdowska Izabela, Sobolewski Dariusz, Olejnik Jadwiga, Zabrocki Janusz, Borovicková Lenka, Slaninová Jiřina, Lammek Bernard: Analogues of Neurohypophyseal Hormones, Oxytocin and Arginine Vasopressin, Conformationally Restricted in the N-Terminal Part of the Molecule. J. Med. Chem. 2006, 49, 2016. <https://doi.org/10.1021/jm058038f>
• Manning Maurice, Cheng Ling Ling, Stoev Stoytcho, Wo Nga Ching, Chan W. Y, Szeto Hazel H., Durroux Thierry, Mouillac Bernard, Barberis Claude: Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban. J. Peptide Sci. 2005, 11, 593. <https://doi.org/10.1002/psc.667>
• Derdowska Izabela, Prahl Adam, Kowalczyk Wioleta, Janecki Marcin, Melhem Samed, Trzeciak Henryk I., Lammek Bernard: Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties. European Journal of Medicinal Chemistry 2005, 40, 63. <https://doi.org/10.1016/j.ejmech.2004.09.011>
• Manning Maurice, Stoev Stoytcho, Cheng Ling Ling, Ching Wo Nga, Chan W.Y.: Design of Oxytocin Antagonists, which are more Selective than Atosiban. Journal of Peptide Science 2001, 7, 449. <https://doi.org/10.1002/psc.339>
• Łempicka E., Derdowska I., Jastrze¸bska B., Lammek B., Kunčarova P., Slaninova J.: Analogs of oxytocin conformationally restricted in the N‐terminal part of the molecule. The Journal of Peptide Research 2001, 57, 162. <https://doi.org/10.1034/j.1399-3011.2001.00805.x>
• Procházka Zdenko, Žertová Miroslava, Slaninová Jiřina: The analogs of oxytocin and D-homoarginine vasopressin with bulky substituted phenylalanine in position 2. Lett Pept Sci 2000, 7, 179. <https://doi.org/10.1007/BF02443586>
• Tóth Gábor K., Bakos Krisztina, Penke Botond, Pávó Imre, Varga Csaba, Török Gabriella, Péter Antal, Fülöp Ferenc: Synthesis of oxytocin antagonists containing conformationally constrained amino acids in position 2. Bioorganic & Medicinal Chemistry Letters 1999, 9, 667. <https://doi.org/10.1016/S0960-894X(99)00041-4>
• PROCHAZKA Z., SLANINOVA J.: ChemInform Abstract: Amino Acids and Peptides. Part 238. 1‐ and 2‐Naphthylalanine Analogues of Oxytocin and Vasopressin. ChemInform 1996, 27. <https://doi.org/10.1002/chin.199618197>